SG Americas Securities LLC Purchases 34,926 Shares of Tempus AI, Inc. $TEM

SG Americas Securities LLC raised its position in Tempus AI, Inc. (NASDAQ:TEM) by 202.1% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 52,205 shares of the company’s stock after purchasing an additional 34,926 shares during the period. SG Americas Securities LLC’s holdings in Tempus AI were worth $3,317,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Calamos Advisors LLC increased its position in shares of Tempus AI by 85.4% in the 2nd quarter. Calamos Advisors LLC now owns 12,575 shares of the company’s stock valued at $799,000 after buying an additional 5,793 shares in the last quarter. Police & Firemen s Retirement System of New Jersey acquired a new position in Tempus AI in the second quarter valued at about $1,993,000. Geode Capital Management LLC grew its stake in Tempus AI by 411.4% in the second quarter. Geode Capital Management LLC now owns 649,420 shares of the company’s stock valued at $41,264,000 after acquiring an additional 522,443 shares during the period. PNC Financial Services Group Inc. increased its holdings in shares of Tempus AI by 6.1% in the second quarter. PNC Financial Services Group Inc. now owns 5,003 shares of the company’s stock worth $318,000 after acquiring an additional 287 shares in the last quarter. Finally, KBC Group NV acquired a new stake in shares of Tempus AI during the second quarter worth about $140,000. 24.22% of the stock is owned by institutional investors.

Tempus AI Stock Up 0.6%

NASDAQ:TEM opened at $66.77 on Wednesday. Tempus AI, Inc. has a twelve month low of $31.36 and a twelve month high of $104.32. The firm has a market capitalization of $11.88 billion, a price-to-earnings ratio of -56.11 and a beta of 4.86. The company has a quick ratio of 3.12, a current ratio of 3.28 and a debt-to-equity ratio of 2.45. The stock’s 50 day moving average price is $84.60 and its two-hundred day moving average price is $71.93.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings data on Tuesday, November 4th. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.16) by $0.05. The company had revenue of $334.21 million during the quarter, compared to the consensus estimate of $328.89 million. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.The firm’s revenue for the quarter was up 84.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.46) EPS. Tempus AI has set its FY 2025 guidance at EPS. Equities research analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Insider Activity

In other news, Director David R. Epstein sold 370 shares of the business’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $90.00, for a total transaction of $33,300.00. Following the transaction, the director directly owned 26,671 shares in the company, valued at $2,400,390. The trade was a 1.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Eric P. Lefkofsky sold 332,500 shares of the firm’s stock in a transaction dated Thursday, September 25th. The shares were sold at an average price of $76.56, for a total transaction of $25,456,200.00. Following the completion of the sale, the chief executive officer owned 9,141,032 shares of the company’s stock, valued at $699,837,409.92. This trade represents a 3.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 1,007,870 shares of company stock valued at $80,663,575 in the last quarter. Company insiders own 26.27% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on TEM. Morgan Stanley boosted their price objective on Tempus AI from $68.00 to $80.00 and gave the company an “overweight” rating in a research report on Tuesday, November 11th. TD Cowen cut shares of Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 price target for the company. in a report on Tuesday, October 21st. HC Wainwright dropped their price objective on shares of Tempus AI from $98.00 to $89.00 and set a “buy” rating on the stock in a report on Friday, November 7th. Piper Sandler cut their price objective on shares of Tempus AI from $105.00 to $80.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 11th. Finally, Guggenheim increased their target price on Tempus AI from $80.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, September 26th. Seven research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Tempus AI presently has a consensus rating of “Hold” and an average target price of $80.00.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.